Ixchiq® (Chikungunya vaccine, live) – FDA and CDC recommend pause in use in 60 years and older
May 9, 2025 - The FDA and the CDC recommended a pause in the use of Valneva’s Ixchiq (Chikungunya vaccine, live) in individuals 60 years of age and older while the Agencies investigate postmarketing reports of serious adverse events, including neurologic and cardiac events, in individuals who have received the vaccine.
Top